Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For mothers (Study Arms 1, 2, and 5):
- Mothers whose newborn was born weighing between 1,000 and 2,000 grams (roughly 2.2 to 4.4 pounds)
- Mothers whose baby has been admitted to the Women and Neonates Hospital-University Teaching Hospital Neonatal Intensive Care Unit (NICU) for more than 48 hours
- Mothers whose baby is a stable preterm infant receiving or being considered for kangaroo mother care (skin-to-skin holding care) in the NICU or after NICU discharge
- Mothers who are 16 years of age or older
- Mothers who live within Lusaka Province and do not plan to move away in the next 18 months
For parents and trusted support people (Study Arm 3):
- Mothers and fathers whose baby has already been enrolled in this study
- A trusted family member or close friend of an enrolled mother
- Mothers and fathers who are 16 years of age or older
- Family members or friends who are 18 years of age or older
For fathers (Study Arm 4):
- Fathers whose baby has already been enrolled in this study
- Fathers who are 16 years of age or older
Who may not be able to join:
For mothers (Study Arms 1, 2, and 5):
- Mothers who are currently receiving treatment for depression and/or anxiety
- Mothers who do not give their consent to take part
- Mothers aged 16–17 whose own parent or guardian has not also given consent for their participation
For family members and support people (Study Arm 3):
- Family members or support people who do not consent to taking part in the study
For fathers (Study Arm 4):
- Fathers who are currently receiving treatment for depression and/or anxiety
- Fathers who do not give their informed consent to take part
- Fathers aged 16–17 whose own parent or guardian has not also given consent for their participation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Albert Manasyan, MD, MPH, Centre for Infectious Disease Research in Zambia
Phone: +260976448994
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Mothers with Postpartum Depression (PPD)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.